Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
8 April 2024 |
Main ID: |
NCT02669160 |
Date of registration:
|
27/01/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Tolerance of a Motorized Orthosis Reproducing Walking Movement vs Conventional Standing-up Devices in Child With CP
EOMEC/CP |
Scientific title:
|
Tolerance of a Motorized Orthosis Reproducing Walking Movement Versus Conventional Passive Standing-up Devices in Children With Cerebral Palsy : A Non-inferiority, Randomised, Multicenter, Controlled Trial |
Date of first enrolment:
|
November 2015 |
Target sample size:
|
25 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02669160 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Jean-François Catanzariti, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
GHICL |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- CP children from 6 to 16 years old, and being less than 150 cms, able to receive a 30
minutes verticalization session (standard practice) without sign of discomfort or
intolerance
- Communicating children
- Children who had never walked
Exclusion Criteria:
- Children presenting uncontrolled epileptic seizures
- No social insurance affiliation
- Refuse to participate in the study
- Orthopaedic surgery in 6 months which precede the inclusion.
- Injection of botulinum toxin in the 6 months which precede the inclusion.
- Previous neurotomy
Age minimum:
6 Years
Age maximum:
16 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
CP (Cerebral Palsy)
|
Intervention(s)
|
Device: PC Innowalk
|
Device: Conventional passive stander
|
Primary Outcome(s)
|
Tolerance of pain according to the scale PPP (paediatric pain profile)
[Time Frame: 6 weeks]
|
Secondary Outcome(s)
|
Number of days of utilization of the verticalization system until first complication or withdrawal of the study.
[Time Frame: 6 weeks]
|
Stress evaluation measured by the change in heart rate from baseline linked to the verticalization system
[Time Frame: 6 weeks]
|
Lower limb muscular strength measured by the Ashworth scale
[Time Frame: 6 weeks]
|
Identification and quantification (percentage) of adverse events and complications linked to the verticalization system
[Time Frame: 6 weeks]
|
Lower limb articular amplitudes measured by a goniometer
[Time Frame: 6 weeks]
|
Selective motor control measured by the CMS/Boyd scale
[Time Frame: 6 weeks]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|